{"doc_id": "33646265", "type of study": "Therapy", "title": "", "abstract": "Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.\nThe efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features.\nSARS-CoV-2-specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics.\nWe longitudinally studied SARS-CoV-2-specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion.\nWe quantified T cells reactive to structural proteins (M, NP, and Spike) using ELISpot and cytokine secretion in whole blood.\nFrequencies of SARS-CoV-2-specific T cells were similar between asymptomatic and symptomatic individuals, but the former showed an increased IFN-\u03b3 and IL-2 production.\nThis was associated with a proportional secretion of IL-10 and proinflammatory cytokines (IL-6, TNF-\u03b1, and IL-1\u03b2) only in asymptomatic infection, while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2-specific T cell activation in symptomatic individuals.\nThus, asymptomatic SARS-CoV-2-infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.\n\u00a9 2021 Le Bert et al.\n", "Evidence Map": {"Enrollment": [{"term": "asymptomatic SARS-CoV-2 infection", "negation": "affirmed", "UMLS": {}, "start": 61, "end": 94}, {"term": "SARS-CoV-2 without symptoms", "negation": "affirmed", "UMLS": {}, "start": 53, "end": 80}, {"term": "asymptomatic", "negation": "affirmed", "UMLS": {}, "start": 69, "end": 81}, {"term": "symptomatic", "negation": "affirmed", "UMLS": {}, "start": 70, "end": 81}, {"term": "asymptomatic infection", "negation": "affirmed", "UMLS": {}, "start": 126, "end": 148}, {"term": "asymptomatic SARS-CoV-2-infected", "negation": "affirmed", "UMLS": {}, "start": 7, "end": 39}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection .", "Evidence Elements": {"Participant": [{"term": "asymptomatic SARS-CoV-2 infection", "negation": "affirmed", "UMLS": {}, "start": 61, "end": 94}], "Intervention": [], "Outcome": [{"term": "virus-specific cellular immune response", "negation": "affirmed", "UMLS": {}, "start": 18, "end": 57}], "Observation": [{"term": "Highly functional", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 17}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "SARS-CoV-2-specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics .", "Evidence Elements": {"Participant": [{"term": "SARS-CoV-2 without symptoms", "negation": "affirmed", "UMLS": {}, "start": 53, "end": 80}], "Intervention": [], "Outcome": [{"term": "SARS-CoV-2-specific T cells", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 27}], "Observation": [{"term": "nonpathological yet protective characteristics", "negation": "affirmed", "UMLS": {}, "start": 94, "end": 140}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "We longitudinally studied SARS-CoV-2-specific T cells in a cohort of asymptomatic ( n = 85 ) and symptomatic ( n = 75 ) COVID-19 patients after seroconversion .", "Evidence Elements": {"Participant": [{"term": "asymptomatic", "negation": "affirmed", "UMLS": {}, "start": 69, "end": 81}, {"term": "symptomatic", "negation": "affirmed", "UMLS": {}, "start": 70, "end": 81}], "Intervention": [], "Outcome": [{"term": "SARS-CoV-2-specific T cells", "negation": "affirmed", "UMLS": {}, "start": 26, "end": 53}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "We quantified T cells reactive to structural proteins ( M , NP , and Spike ) using ELISpot and cytokine secretion in whole blood .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "T cells reactive to structural proteins", "negation": "affirmed", "UMLS": {}, "start": 14, "end": 53}, {"term": "cytokine", "negation": "affirmed", "UMLS": {}, "start": 95, "end": 103}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Frequencies of SARS-CoV-2-specific T cells were similar between asymptomatic and symptomatic individuals , but the former showed an increased IFN-\u03b3 and IL-2 production .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "asymptomatic", "negation": "affirmed", "UMLS": {}, "start": 64, "end": 76, "has_relation": "N/A"}, {"term": "symptomatic", "negation": "affirmed", "UMLS": {}, "start": 65, "end": 76, "has_procedure": [{"text": "symptomatic", "maps_to": "C5243901:Symptomatic", "start": 0, "end": 11}], "has_relation": "N/A"}], "Outcome": [{"term": "Frequencies of SARS-CoV-2-specific T cells", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 42}, {"term": "IFN-\u03b3", "negation": "affirmed", "UMLS": {}, "start": 142, "end": 147}, {"term": "IL-2", "negation": "affirmed", "UMLS": {}, "start": 152, "end": 156}], "Observation": [{"term": "similar", "negation": "affirmed", "UMLS": {}, "start": 48, "end": 55}, {"term": "increased", "negation": "affirmed", "UMLS": {}, "start": 132, "end": 141}], "Count": []}, "Evidence Propositions": [{"Intervention": [{"term": "asymptomatic", "has_relation": "N/A"}, {"term": "symptomatic", "has_procedure": [{"text": "symptomatic", "maps_to": "C5243901:Symptomatic", "start": 0, "end": 11}], "has_relation": "N/A"}], "Observation": "similar", "Outcome": "Frequencies of SARS-CoV-2-specific T cells", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "This was associated with a proportional secretion of IL-10 and proinflammatory cytokines ( IL-6 , TNF-\u03b1 , and IL-1\u03b2 ) only in asymptomatic infection , while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2-specific T cell activation in symptomatic individuals .", "Evidence Elements": {"Participant": [{"term": "asymptomatic infection", "negation": "affirmed", "UMLS": {}, "start": 126, "end": 148}], "Intervention": [{"term": "SARS-CoV-2-specific T", "negation": "affirmed", "UMLS": {}, "start": 229, "end": 250, "has_relation": "N/A"}], "Outcome": [{"term": "secretion of IL-10 and proinflammatory cytokines", "negation": "affirmed", "UMLS": {}, "start": 40, "end": 88}, {"term": "IL-6", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 95}, {"term": "TNF-\u03b1", "negation": "affirmed", "UMLS": {}, "start": 98, "end": 103}, {"term": "IL-1\u03b2", "negation": "affirmed", "UMLS": {}, "start": 110, "end": 115}], "Observation": [{"term": "proportional", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 39}, {"term": "disproportionate secretion of inflammatory cytokines", "negation": "affirmed", "UMLS": {}, "start": 159, "end": 211}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Thus , asymptomatic SARS-CoV-2-infected individuals are not characterized by weak antiviral immunity ; on the contrary , they mount a highly functional virus-specific cellular immune response .", "Evidence Elements": {"Participant": [{"term": "asymptomatic SARS-CoV-2-infected", "negation": "affirmed", "UMLS": {}, "start": 7, "end": 39}], "Intervention": [], "Outcome": [{"term": "antiviral immunity", "negation": "negated", "UMLS": {}, "start": 82, "end": 100}, {"term": "virus-specific", "negation": "negated", "UMLS": {}, "start": 152, "end": 166}], "Observation": [{"term": "weak", "negation": "negated", "UMLS": {}, "start": 77, "end": 81}, {"term": "highly functional", "negation": "negated", "UMLS": {}, "start": 134, "end": 151}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "\u00a9 2021 LeBert et al .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}